This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2026 - Rare Disease Summit
March 17-19, 2026
Pre-Conference Workshops on March 16, 2026Sheraton Philadelphia Downtown | Philadelphia, PA

Jill Yersak, Ph.D.
Senior Director of Patient Advocacy & Government Affairs at Soleno Therapeutics
Speaker

Profile

Dr. Jill Yersak is the Senior Director of Patient Advocacy & Government Affairs at Soleno Therapeutics, a biopharmaceutical company developing novel therapies for rare diseases. With over 20 years of experience across academia, non-profit, and industry, she is a passionate leader committed to elevating patient voices and driving meaningful impact. At Soleno, Jill built the U.S. patient advocacy and government affairs functions and partners closely with the Prader-Willi syndrome community to ensure their insights guide key initiatives. She leads with curiosity, collaboration, and enthusiasm. Jill holds a Ph.D. in molecular cell biology with a focus on neurodegenerative diseases.

Agenda Sessions

  • Maximizing Patient Advocacy Partnerships – Creating Strategic Value Through Collaborative Engagement

    8:15am